PD is the second most common neurodegenerative disease, after Alzheimer’s disease. An estimated 7 to 10 million people worldwide are living with PD. There has been significant research over the past 50 years, resulting in important discoveries and treatments which provide relief. We first supported a clinical study for PD in 2016 and continue to invest in our technological solutions to support clinical trials in this area.
Combining the best emerging wearable technology together with our digital platform for analysis of biosensor data in Parkinson’s Disease.